[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi:10.3322/caac.21660 |
[2] |
Adamus A, Müller P, Nissen B, et al. GCSH antisense regulation determines breast cancer cells' viability[J]. Sci Rep, 2018, 8(1): 15399. DOI: 10.1038/s41598-018-33677-4. doi:10.1038/s41598-018-33677-4pmid:30337557 |
[3] |
Dufresne J, Bowden P, Thavarajah T, et al. The plasma peptides of breast versus ovarian cancer[J]. Clin Proteomics, 2019, 16: 43. DOI: 10.1186/s12014-019-9262-0. doi:10.1186/s12014-019-9262-0 |
[4] |
Zhai T, Muhanhali D, Jia X, et al. Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer[J]. Endocrine, 2019, 66(3): 573-584. DOI: 10.1007/s12020-019-02021-9. doi:10.1007/s12020-019-02021-9pmid:31332712 |
[5] |
Kałuzińska Ż, Kołat D, Bednarek AK, et al. PLEK2, RRM2, GCSH: a novel WWOX-dependent biomarker triad of glioblastoma at the crossroads of cytoskeleton reorganization and metabolism alterations[J]. Cancers (Basel), 2021, 13(12): 2955. DOI: 10.3390/cancers13122955. doi:10.3390/cancers13122955 |
[6] |
Almhanna K, Cubitt CL, Zhang S, et al. MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines[J]. Cancer Biol Ther, 2013, 14(10): 932-936. DOI: 10.4161/cbt.25939. doi:10.4161/cbt.25939pmid:23917345 |
[7] |
Ajani JA, Javle M, Eng C, et al. Phase Ⅰ study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmaxand improved tolerability, in patients with solid tumors[J]. Invest New Drugs, 2020, 38(6): 1763-1773. DOI: 10.1007/s10637-020-00939-w. doi:10.1007/s10637-020-00939-w |
[8] |
Camera S, Deleporte A, Bregni G, et al. MOMENTUM: a phase Ⅰ trial investigating 2 schedules of capecitabine with aflibercept in patients with gastrointestinal and breast cancer[J]. Clin Colorectal Cancer, 2020, 19(4): 311-318.e1. DOI: 10.1016/j.clcc.2020.05.007. doi:10.1016/j.clcc.2020.05.007 |
[9] |
Ono S, Kawada K, Dohi O, et al. Linked color imaging focused on neoplasm detection in the upper gastrointestinal tract: a randomized trial[J]. Ann Intern Med, 2021, 174(1): 18-24. DOI: 10.7326/M19-2561. doi:10.7326/M19-2561 |
[10] |
Vranić S, Bešlija S, Gatalica Z. Targeting HER2 expression in cancer: new drugs and new indications[J]. Bosn J Basic Med Sci, 2021, 21(1): 1-4. DOI: 10.17305/bjbms.2020.4908. doi:10.17305/bjbms.2020.4908 |
[11] |
Davies R, Liu L, Taotao S, et al. CRISPRi enables isoform-specific loss-of-function screens and identification of gastric cancer-specific isoform dependencies[J]. Genome Biol, 2021, 22(1): 47. DOI: 10.1186/s13059-021-02266-6. doi:10.1186/s13059-021-02266-6pmid:33499898 |
[12] |
Dong N, Ma X, Shen J, et al. Identification and validation of critical genes with prognostic value in gastric cancer[J]. Front Cell Dev Biol, 2022, 10: 1072062. DOI: 10.3389/fcell.2022.1072062. doi:10.3389/fcell.2022.1072062 |
[13] |
Ucaryilmaz Metin C, Ozcan G. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer[J]. BMC Cancer, 2022, 22(1): 692. DOI: 10.1186/s12885-022-09736-5. doi:10.1186/s12885-022-09736-5pmid:35739492 |
[14] |
Shah RH, Northrup H, Hixson JE, et al. Genetic association of the glycine cleavage system genes and myelomeningocele[J]. Birth Defects Res A Clin Mol Teratol, 2016, 106(10): 847-853. DOI: 10.1002/bdra.23552. doi:10.1002/bdra.23552 |
[15] |
Yoshikawa A, Nishimura F, Inai A, et al. Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes[J]. Psychiatry Clin Neurosci, 2018, 72(3): 168-179. DOI: 10.1111/pcn.12628. doi:10.1111/pcn.12628 |
[16] |
Lin Y, Zheng Z, Sun W, et al. A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia[J]. BMC Med Genet, 2018, 19(1): 5. DOI: 10.1186/s12881-017-0517-1. doi:10.1186/s12881-017-0517-1pmid:29304759 |
[17] |
Hungermann D, Schmidt H, Natrajan R, et al. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer[J]. J Pathol, 2011, 224(4): 517-528. DOI: 10.1002/path.2938. doi:10.1002/path.2938 |
[18] |
Huang J, Shi J, Wu P, et al. Identification of a novel cuproptosis-related gene signature and integrative analyses in thyroid cancer[J]. J Clin Med, 2023, 12(5): 2014. DOI: 10.3390/jcm12052014. doi:10.3390/jcm12052014 |
[19] |
Kim D, Fiske BP, Birsoy K, et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance[J]. Nature, 2015, 520(7547): 363-367. DOI: 10.1038/nature14363. doi:10.1038/nature14363 |
[20] |
Perry CJ, Finch P, Müller-Taubenberger A, et al. A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models[J]. Br J Pharmacol, 2020, 177(4): 912-928. DOI: 10.1111/bph.14892. doi:10.1111/bph.14892 |
[21] |
Vazquez A, Markert EK, Oltvai ZN. Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation[J]. PLoS One, 2011, 6(11): e25881. DOI: 10.1371/journal.pone.0025881. doi:10.1371/journal.pone.0025881 |
[22] |
Rahimifard M, Baeeri M, Mousavi T, et al. Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: focusing on oxidative stress, and cell cycle arrest[J]. Front Pharmacol, 2023, 13: 1068863. DOI: 10.3389/fphar.2022.1068863. doi:10.3389/fphar.2022.1068863 |